CT/NG Testing Market – By Product Type (Consumables, Instruments/Analyzers), By Test Type (Laboratory Testing, Point-of-Care Testing), By Technology (INAAT, PCR, Immunodiagnostics), By End-use (Hospitals & Clinics, Diagnostic Labs) & Forecast, 2024 – 2032
Report ID: GMI9397
|
Published Date: May 2024
|
Report Format: PDF
Download Free PDF
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 15
Tables & Figures: 151
Countries covered: 23
Pages: 110
Download Free PDF

CT/NG Testing Market
Get a free sample of this reportGet a free sample of this report CT/NG Testing Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
CT/NG Testing Market Size
CT/NG Testing Market size was valued at USD 1.5 billion in 2023 and is anticipated to witness growth at a CAGR of 7.1% between 2024 and 2032, driven by the increasing incidence of sexually transmitted infections (STIs) coupled with growing awareness and screening programs.
There has been a global increase in the prevalence of sexually transmitted infections, including chlamydia (CT) and gonorrhea (NG). For instance, according to an article published by the World Health Organization in 2023, more than 1 million sexually transmitted infections (STIs) are acquired every day worldwide, the majority of which are asymptomatic. Factors contributing to this rise include changes in sexual behavior, inadequate access to preventive measures, lack of STI education, and evolving patterns of STI transmission. As STI rates continue to escalate, there is a growing need for effective screening and diagnostic tools to detect and manage these infections promptly.
Moreover, increased awareness about the prevalence and risks associated with chlamydia (CT) and gonorrhea (NG) infections is driving public health campaigns aimed at educating individuals about the importance of STI screening. These campaigns, often conducted by government health agencies, non-profit organizations, and healthcare providers, raise awareness about the asymptomatic nature of these infections, their potential complications, and the importance of regular testing, especially among sexually active populations and high-risk groups. Therefore, the aforementioned factors drive the adoption of CT/NG testing devices among individuals and healthcare providers.
CT/NG testing refers to the diagnostic process used to detect the presence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in individuals. These tests are performed on various specimen types, including urine, genital swabs, vaginal swabs, cervical swabs, urethral swabs, and rectal swabs, depending on the anatomical site of infection. CT/NG testing plays a crucial role in identifying and diagnosing these infections, allowing for prompt treatment and prevention of complications.
CT/NG Testing Market Trends
CT/NG Testing Market Analysis
Based on product type, the market is segmented into consumables and instruments/analyzers. The consumables segment held a dominant market share of 74.9% in 2023.
Based on test type, the CT/NG testing market is classified into laboratory testing and point-of-care (POC) testing. The laboratory testing segment accounted for the highest market share and was valued at USD 1.1 billion in 2023.
Based on technology, the CT/NG testing market is classified into isothermal nucleic acid amplification technology, polymerase chain reaction, immunodiagnostics, and other technologies. The polymerase chain reaction segment is anticipated to grow at a CAGR of 7.4% to reach USD 1.3 billion by 2032.
Based on end-use, the CT/NG testing market is categorized into hospitals & clinics, diagnostic laboratories, home care setting, and other end-users. The hospitals & clinics segment is projected to reach USD 1.2 billion by 2032.
North America CT/NG testing market size in 2023 was valued at USD 533.4 million and is predicted to grow at a CAGR of 6.6% over the analysis timeframe.
U.S. CT/NG testing market is anticipated to grow at a CAGR of 6.5% to reach USD 878.9 million by the end of the forecast timeframe.
France CT/NG testing market is projected to grow remarkably in the coming years.
Japan is experiencing high market growth in the CT/NG testing market.
CT/NG Testing Market Share
The CT/NG testing industry is characterized by the presence of several established and emerging players that offer a variety of products and services across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.
CT/NG Testing Market Companies
Prominent players operating in the CT/NG testing industry include:
CT/NG Testing Industry News:
The CT/NG testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product Type
Market, By Test Type
Market, By Technology
Market, By End-use
The above information is provided for the following regions and countries: